1-1041976-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_198576.4(AGRN):​c.1198C>T​(p.Arg400Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000261 in 1,611,772 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R400Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00098 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00019 ( 3 hom. )

Consequence

AGRN
NM_198576.4 missense

Scores

1
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 0.489

Publications

4 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01354447).
BP6
Variant 1-1041976-C-T is Benign according to our data. Variant chr1-1041976-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 474098.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.1198C>T p.Arg400Trp missense_variant Exon 7 of 36 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.1198C>T p.Arg400Trp missense_variant Exon 7 of 36 1 NM_198576.4 ENSP00000368678.2
AGRNENST00000651234.1 linkc.883C>T p.Arg295Trp missense_variant Exon 6 of 38 ENSP00000499046.1
AGRNENST00000652369.2 linkc.883C>T p.Arg295Trp missense_variant Exon 6 of 35 ENSP00000498543.1
AGRNENST00000620552.4 linkc.784C>T p.Arg262Trp missense_variant Exon 7 of 39 5 ENSP00000484607.1

Frequencies

GnomAD3 genomes
AF:
0.000979
AC:
149
AN:
152160
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00309
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000318
AC:
78
AN:
245578
AF XY:
0.000276
show subpopulations
Gnomad AFR exome
AF:
0.00305
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000137
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.000186
AC:
271
AN:
1459494
Hom.:
3
Cov.:
77
AF XY:
0.000185
AC XY:
134
AN XY:
726134
show subpopulations
African (AFR)
AF:
0.00287
AC:
96
AN:
33448
American (AMR)
AF:
0.000269
AC:
12
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51668
Middle Eastern (MID)
AF:
0.00159
AC:
9
AN:
5664
European-Non Finnish (NFE)
AF:
0.000101
AC:
112
AN:
1111670
Other (OTH)
AF:
0.000381
AC:
23
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000978
AC:
149
AN:
152278
Hom.:
0
Cov.:
34
AF XY:
0.000860
AC XY:
64
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00308
AC:
128
AN:
41564
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
67998
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000286
Hom.:
0
Bravo
AF:
0.00106
ESP6500AA
AF:
0.00273
AC:
12
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000454
AC:
55
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Congenital myasthenic syndrome 8 Uncertain:2Benign:1
Sep 01, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 04, 2017
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The observed variant c.1198C>T (p.Arg400Trp) has a minor allele frequency of 0.0016 and 0.0005 in 1000 Genomes and ExAC databases respectively. The in silico prediction of the variant is benign by MutationTaster2, damaging by SIFT, and probably damaging by PolyPhen2. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 23, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

not specified Benign:1
Jul 30, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: AGRN c.1198C>T (p.Arg400Trp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00026 in 1610860 control chromosomes in the gnomAD database (v4.1 dataset), including 3 homozygotes. The variant was found predominantly within the African or African-American subpopulation at a frequency of 0.003. The observed variant frequency within African or African-American control individuals, together with the presence in homozygotes suggest that the variant might be benign. To our knowledge, no occurrence of c.1198C>T in individuals affected with Congenital Myasthenic Syndrome-8 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 474098). Based on the evidence outlined above, the variant was classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
19
DANN
Uncertain
1.0
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.11
N
LIST_S2
Pathogenic
0.98
D;D
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.014
T;T
MetaSVM
Benign
-0.61
T
MutationAssessor
Uncertain
2.1
M;.
PhyloP100
0.49
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-2.5
N;.
REVEL
Benign
0.25
Sift
Uncertain
0.013
D;.
Sift4G
Uncertain
0.0030
D;D
Vest4
0.22
MVP
0.84
MPC
0.49
ClinPred
0.024
T
GERP RS
0.23
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
gMVP
0.28
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149636063; hg19: chr1-977356; COSMIC: COSV65069633; COSMIC: COSV65069633; API